„Labtec joins CPHI Frankfurt and Bio Europe Düsseldorf“

The International Contract Service Event (“ICSE”), taking place in Frankfurt from 25th until 27th October 2011, is co-located with the “CPhI Worldwide ” which is the biggest international fair for the pharmaceutical industry. Professionals from more than 125 countries and from a broad variety of companies will come to Frankfurt in order to evaluate new trends and to initiate promising business opportunities.

The ICSE focuses on outsourcing of different services for pharmaceutical companies. The scope of the event ranges from contract research, clinical trials and analytical services to contract development and contract manufacturing. Labtec and its team of experts welcome you in Frankfurt at booth 41E16.

The Bio-Europe , which is held in Düsseldorf from 31st October until 2nd November 2011, is Europe’s largest partnering conference attracting attendee from biotech and pharma. With almost 15.000 face to face meetings during three days the event states an attractive platform to meet decision makers from more than 50 countries. Labtec is looking forward to meet interested companies in Düsseldorf at booth 64.

At both events, Labtec is going to present its capabilities not only as a contract development company for transdermal systems (TDS) and fast dissolving oral films (Rapidfilm®) but also as a cGMP contract manufacturer for the mentioned drug delivery systems.

In addition, Labtec will be pleased to introduce interested parties to its global licensing opportunities comprising transdermal patches and Rapidfilms®. Labtec can offer development projects but also approved products ready to be placed on the European market.

If you are interested in an appointment, please contact us:

Labtec GmbH
Tel: +49 (0) 2173 9735-0
Email: Contact us
www.labtec-pharma.com

About Labtec GmbH

Founded in 1990, Labtec has quickly become one of the leading drug delivery development companies in the transdermal and topical patch arena, later also leading the market with fast dissolving oral films (Rapidfilm®) in Europe.

Since 2008 Labtec is a subsidiary of tesa SE – a member of the Beiersdorf group of companies – and represents tesa’s pharmaceutical business. The company offers contract development and contract manufacturing of patches and oral film strips to the pharmaceutical industry. In 2009, Labtec started operations at tesa’s new 3,000 m² GMP manufacturing site for patches and oral films. For press releases and more information about Labtec, please visit: www.labtec-pharma.com